When a biological drug patent expires, alternative biosimilar
products are developed. The development of biosimilar products is
complicated and involves numerous considerations and steps. The
assessment of biosimilarity and interchangeability is also
complicated and difficult. Biosimilar Drug Product Development
presents current issues for the development of biosimilars and
gives detailed reviews of its various stages and contributing
factors as well as relevant regulatory pathways and pre- and
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!